Biliary excretion of digoxin in man
- 1 April 1976
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 19 (4) , 410-415
- https://doi.org/10.1002/cpt1976194410
Abstract
We have measured the biliary excretion of 3 H-digoxin in normal subjects by intestinal perfusion methods which impose minimal interruption of the enterohepatic circulation. In contrast to data obtained in patients with liver disease and postoperative patients with biliary fistulas. our data show that about 30% of an intravenous dose of 3H-digoxin reaches the digestive tract in 24 hr. Most of the excreted radioactivity is chloroform-soluble and presumably reabsorbable and most of this fraction is probably biologically active drug. The results suggest that (1) consideration of hepatobiliary function may be relevant in observations regarding digoxin pharmacokinetics and that this route may be exploited in trials of therapy designed to shorten the duration of digoxin intoxication.This publication has 5 references indexed in Scilit:
- The Clinical Pharmacology of Digitalis GlycosidesThe Lancet Healthy Longevity, 1968
- Tritiated Digoxin Excretion of Patients Following Renal TransplantationCirculation, 1968
- SPECIES DIFFERENCE IN DURATION OF ACTION OF CARDIAC GLYCOSIDES1967
- DISTRIBUTION AND EXCRETION OF TRITIATED SUBSTANCES IN EXPERIMENTAL ANIMALS FOLLOWING ADMINISTRATION OF DIGOXIN-3H1966
- The Metabolism of Tritiated Digoxin in Cirrhotic PatientsGastroenterology, 1964